Home/ Stocks/ CVRX

CVRx, Inc. Common Stock

CVRX XNAS

$2.39 -3.53 (-59.42%) ▼ 15-min delayed

Open

$3.01

High

$3.08

Low

$2.30

Volume

14.74M

Market Cap

$157.62M

About CVRx, Inc. Common Stock

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

Sector: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Employees: 223 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$14.77M	$-13,120,000	$-0.50
FY 2025	$56.65M	$-53,306,000	$-2.04
Q3 2025	$14.69M	$-12,870,000	$-0.49
Q2 2025	$13.59M	$-14,736,000	$-0.57

Earnings & Analyst Ratings

Next Earnings: Tue, Nov 3, 2026

Calendar →

Related Market News

No specific coverage for CVRX yet. Check out our latest market news or earnings calendar.

Get CVRX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on CVRx, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.